(IN BRIEF) Newcastle University’s Discover Festival, a free family-friendly event, will take place on Saturday, June 7, 2025, offering a day of interactive learning and entertainment. Over 70 activities will showcase the university’s pioneering research, including hands-on experiences in robotics, … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Entertainment, Financial, Industrial, Investment, Management, Marketing, Media, News, Science, Technology, United Kingdom
Tagged AI, chemical reactions, community event, Discover Festival, Education, family-friendly, food festival, interactive activities, Mind-Controlled Machines, musical performances, Newcastle University, RESEARCH, Robo Rally, robotics, STEM activities, university events
(IN BRIEF) Researchers at Newcastle University have discovered a new biological mechanism explaining why some patients do not respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors. They identified T regulatory cells (Tregs) as key drivers of ICB … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged anti-CD30, Brentuximab Vedotin, Cancer Immunotherapy, cancer research, combination treatment, ICB resistance, immune checkpoint blockade, immunotherapy breakthroughs, lung cancer, melanoma, metastatic cancer, Newcastle University, pancreatic cancer, PD-1, skin cancer, solid tumors, T regulatory cells
(IN BRIEF) The University of Glasgow has appointed Professor Emma Thomson as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), after she served as Interim Director from February. An expert in emerging infectious diseases, Professor … Read the full press release
Posted in Education, Healthcare, Science, Technology, United Kingdom
Tagged Centre for Virus Research, COVID-19, CVR, emerging viruses, Glasgow medical research, global health, hepatitis, infectious diseases, MRC, Pandemic Preparedness, Professor Emma Thomson, public health, scientific leadership, University of Glasgow, vaccine trials, viral research, virology
(IN BRIEF) Novartis has announced that its Phase III PSMAddition trial of Pluvicto™ in combination with standard of care (SoC) has met its primary endpoint, showing a significant benefit in radiographic progression-free survival (rPFS) and a positive trend in overall … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged androgen receptor pathway inhibitors, cancer research, clinical trials, FDA approval, FDA regulatory review, metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, mHSPC, Novartis, Novartis oncology, overall survival, Phase III PSMAddition, Pluvicto, progression-free survival, prostate cancer, prostate cancer treatment, PSMA-positive, radioligand therapy, treatment options
(IN BRIEF) Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in pre-menopausal patients with high-risk early breast cancer. The data reveals a 33% reduction in … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged adjuvant treatment, ASCO 2025, Black patients, Breast Cancer Treatment, CDK4/6 inhibitors, DDFS, disparities in healthcare, early breast cancer, EBC, endocrine therapy, HR+/HER2-, invasive disease-free survival, Kisqali®, metastatic breast cancer, Novartis, Phase III NATALEE, post-menopausal, pre-menopausal, recurrence-free survival, RFS, ribociclib, Risk Reduction, survival benefit
(IN BRIEF) Eckert & Ziegler successfully hosted the 3rd annual Boston Radionuclide Theranostics Forum, bringing together industry leaders to discuss radionuclide theranostics’ role in transforming precision oncology. The event featured expert presentations on advancements in radiopharmaceuticals, clinical development challenges, and … Read the full press release
Posted in Berlin, Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Technology
Tagged Boston Radionuclide Theranostics Forum, clinical development, Dr. Harald Hasselmann, Eckert & Ziegler, German American Business Council, Industry innovation, Morrison Foerster, nuclear medicine, patient access, precision oncology, radionuclide theranostics, radiopharmaceutical community, radiopharmaceuticals, radiotherapy, Solomon Partners
(IN BRIEF) Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing on advancements in kidney care, artificial intelligence, fluid management, and hemodiafiltration. Key studies include the … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology
Tagged AI, Andrea Nandorine Ban, artificial intelligence, CONVINCE trial, dialysis, ERA Congress, fluid management, Frank Maddux, Fresenius Medical Care, hemodiafiltration, hemodialysis, kidney disease, medical advancements, nephrology, patient outcomes, Renal Research Institute, RESEARCH
(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Bruton’s tyrosine kinase, BTK inhibitor, clinical data, clinical research, clinical trial, data, disability, disability progression, fenebrutinib, FENopta, Levi Garraway, multiple sclerosis, Phase II, relapse rates, relapsing multiple sclerosis, RMS, Roche, treatment
(IN BRIEF) Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in moderate or severe exacerbations at 52 weeks. However, the AERIFY-2 study did not achieve the … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged adverse events, AERIFY-1, AERIFY-2, Chronic obstructive pulmonary disease, clinical trials, COPD, COVID-19, drug efficacy, Exacerbations, IL33, Itepekimab, moderate exacerbations, monoclonal antibody, partnership, phase 3 study, Regeneron, regulatory authorities, research and development, Sanofi, severe exacerbations, therapeutic development
(IN BRIEF) Valio is a key partner in the EU-funded PRIMARY project, which aims to transform agricultural by-products into valuable resources. As part of the project, Valio is exploring grass biorefinery innovations, including using grass juice to fortify feed protein … Read the full press release
Posted in Agriculture, Business, Environment, Estonia, European Union, Financial, Finland, Food & Beverage, Government, Greece, Industrial, Investment, Management, News, Science, Small Business, Technology
Tagged agricultural by-products, bio-based materials, bioeconomy, bioenergy, biorefinery, cotton by-products, dairy farms, Estonia, EU, fermentation, Finland, grass biorefineries, Greece, Horizon Europe, olive residues, partnership, PRIMARY project, protein fortification, protein self-sufficiency, renewable energy, sustainability, Valio, VTT Technical Research Centre
(IN BRIEF) SGS has received approval from OSHA to expand its global network of Nationally Recognized Testing Laboratories (NRTLs) to new locations in Europe and Asia. Starting January 22, 2025, SGS will provide testing and certification for U.S. market products … Read the full press release
Posted in Business, European Union, Financial, Government, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Switzerland, Technology
Tagged ASME A17.5, Brussels, certification, Elevator and Escalator Electrical Equipment, global network, Gyeonggi-do, international testing, John Ciliege, New Taipei City, North America, NRTL, OSHA, partnership, product compliance, product safety, Puchheim, Safety Standards, SGS, SGS North America Mark, sustainability, testing, U.S. market, Yokohama
(IN BRIEF) SGS has strengthened its support for Canadian farmers by offering extensive seed testing services across the country, combining local expertise with global testing standards. With laboratories in key agricultural regions such as Grande Prairie and Sherwood Park, SGS … Read the full press release
Posted in Agriculture, Business, Environment, Financial, Government, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged aging tests, agricultural testing services, Canadian agriculture, cold stress, Crop Science, disease diagnostics, germination rates, global markets, Grande Prairie, Holly Gelech, partnership, planting strategies, regulatory compliance, seed chemistry, seed health, seed testing, seed vigor, SGS, Sherwood Park laboratory, stress tolerance, sustainability
(IN BRIEF) A new study by Unilever, in collaboration with the University of Liverpool, has revealed a potential link between the skin microbiome and psychological wellbeing. The research found that higher levels of the skin bacterium Cutibacterium, especially on the … Read the full press release
Posted in Apparel, Fashion & Beauty, Business, Financial, Healthcare, Industrial, Investment, Management, News, Retail, Science, Technology, United Kingdom
Tagged beauty and wellbeing, beauty products, Cutibacterium, Dermalogica, Dove, mental health, microbiome study, mood improvement, Pond’s, psychological wellbeing, R&D, skin microbiome, skin-brain axis, skincare research, stress reduction, Unilever, University of Liverpool, Vaseline
(IN BRIEF) A team of researchers from the University of Copenhagen has revealed groundbreaking findings about insulin resistance, showing that it varies widely on a molecular level even among healthy individuals and those diagnosed with type 2 diabetes. This discovery … Read the full press release
Posted in Business, Denmark, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Anna Krook, Atul Deshmukh, diabetes research, early diagnosis, insulin resistance, Jeppe Kjærgaard Northcote, Karolinska Institutet, molecular signatures, muscle tissue, personalized treatments, precision medicine, proteomics, Steno Diabetes Center, type 2 diabetes, University of Copenhagen
(IN BRIEF) Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid cell engager, which has shown promising results in B-cell depletion, may offer potential breakthroughs in autoimmune diseases, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, antibody therapeutics, autoimmune diseases, B cell depletion, biopharmaceuticals, bispecific myeloid cell engager, clinical-stage, DR-0201, Dren Bio, immunology, lupus, partnership, phagocytosis, Sanofi, SAR448501, therapeutics
(IN BRIEF) TreeFrog Therapeutics has secured €30 million in financing from the European Investment Bank to advance its cell therapy program for Parkinson’s disease and support the development of its internal pipeline targeting diseases with high unmet needs. The funding, … Read the full press release
Posted in Banks, Business, Economy, Environment, Financial, France, Government, Healthcare, Industrial, Investment, Luxembourg, Management, News, Science, Technology
Tagged 3D microtissues, bioreactors, C-Stem, cell therapy, dilutive financing, EIB, European Investment Bank, Healthcare Innovation, InvestEU, iPSCs, Microfluidics, Parkinson's disease, partnership, Regenerative medicine, stem cell biology, sustainability, TreeFrog Therapeutics, venture debt, €30 million financing
(IN BRIEF) University of Glasgow researchers, Dr. Joseph Cameron and Dr. Alex Loch, will lead a study to assess and improve the sustainability of flash chromatography, a widely used chemical purification technique. Funded by the Royal Society of Chemistry’s Sustainable … Read the full press release
Posted in Business, Chemicals, Education, Environment, Financial, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Technology, United Kingdom
Tagged academic research, chemical purification, chemistry research, Dr. Alex Loch, Dr. Joseph Cameron, environmental impact, flash chromatography, Green Chemistry Centre of Excellence, life cycle assessment, recycling, reusability, Royal Society of Chemistry, sustainability, sustainable laboratories, sustainable practices, University of Glasgow
(IN BRIEF) Researchers from the University of Southampton will join the Breast Walk Ever charity event on 8 June 2025 to support Against Breast Cancer and raise funds for vital research into secondary breast cancer. ABC-funded PhD student Grace Hayes … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Media, News, Science, Society, Technology, United Kingdom
Tagged ABC events, Against Breast Cancer, bone metastasis, Breast Walk Ever, Cancer Detection, cancer research, charity event, Deborah Parnell, fundraising, fundraising event, Grace Hayes, Hursley, immunology, immunotherapy, miONCO test, PhD student research, Richard Martin, secondary breast cancer, Southampton researchers, University of Southampton, Winchester
(IN BRIEF) A study from the University of Southampton and the University of Bergen reveals that boys who become overweight during their early teens may inadvertently affect the health of their future children. The research found epigenetic changes in genes … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged adolescent obesity, asthma, childhood obesity, DNA methylation, Dr. Negusse Tadesse Kitaba, epigenetics, generational health, health disparities, health inequalities, lung function, Nature Communications Biology, Norwegian Research Council, Obesity, obesity prevention, Professor Cecilie Svanes, Professor John Holloway, public health, RESEARCH, University of Bergen, University of Southampton
(IN BRIEF) NutriSen, a TUM spin-off, is revolutionizing agriculture with its smart fertilization technology, which provides precise and data-driven fertilizer recommendations. By combining plant data with satellite imagery, the technology helps farmers reduce fertilizer use by up to 20%, benefiting … Read the full press release
Posted in Agriculture, Business, Education, Environment, Financial, Germany, Industrial, Investment, Management, News, Science, Technology
Tagged & innovation in agriculture, agricultural technology, biosensor strips, environmental protection, European Copernicus, EXIST research transfer program, field trials, nitrate measurement, nitrogen reduction, NutriSen, plant measurement, Precision Agriculture, satellite data, smart fertilization, start-up, sustainability, sustainable agriculture, sustainable farming, TUM, Unternehmertum, Xplore
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?